Full name
MARRODENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.90.Z - Non-specialized wholesale trade
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
49.41.Z - Road freight transport
68.10.Z - Real estate activities on own account and development of building projects
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.23.Z - Dental practice
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3,1 | 1,8 | -3,1 | -274,9 |
EBITDA | 5,1 | 8,1 | 4,2 | -48,3 |
Short time liabilities | 64 | 100,6 | 96,2 | -4,4 |
Equity capital | 23,2 | 24,5 | 21,7 | -11,3 |
Operating profit (EBIT) | 3,5 | 6,2 | 2,2 | -65 |
Assets | 89,8 | 128,8 | 122,2 | -5,1 |
Net profit (loss) | 2,4 | 1,3 | -2,8 | -314,6 |
Cash | 8,9 | 20,9 | 9,5 | -54,6 |
Net income from sale | 227,5 | 260,6 | 279,9 | 7,4 |
Liabilities and provisions for liabilities | 66,7 | 104,3 | 100,5 | -3,7 |
Working assets | 81 | 119,5 | 111,7 | -6,5 |
Depreciation | 1,6 | 1,9 | 2 | 5,2 |
% | % | % | p.p. | |
Profitability of capital | 10,4 | 5,3 | -12,8 | -18,1 |
Equity capital to total assets | 25,8 | 19 | 17,8 | -1,2 |
Gross profit margin | 1,4 | 0,7 | -1,1 | -1,8 |
EBITDA Margin | 2,3 | 3,1 | 1,5 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 103 | 141 | 126 | -15 |
Current financial liquidity indicator | 1.2648073434829712 | 1.1873408555984497 | 1.1611647605895996 | 0 |
Net dept to EBITDA | 5.538872241973877 | 6.558547496795654 | 13.029808044433594 | 6,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane